Ensysce Biosciences, Inc. SEC filings ENSC
Ensysce Biosciences, Inc. has 547 filings in SEC EDGAR's recent list, going back to Oct 3, 2017. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3 | Shelf registration | Oct 23, 2026 | — |
| S-3 | Shelf registration | Jun 4, 2026 | — |
| S-8 | Employee stock plan registration | Apr 30, 2026 | — |
| S-3 | Shelf registration | Apr 9, 2026 | — |
| S-3 | Shelf registration | Dec 2, 2025 | — |
| 424B5 | Prospectus supplement | Nov 14, 2025 | — |
| S-8 | Employee stock plan registration | May 2, 2025 | — |
| S-3 | Shelf registration | May 2, 2025 | — |
| S-3 | Shelf registration | Apr 16, 2025 | — |
| S-3 | Shelf registration | Apr 16, 2025 | — |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| S-3 | Shelf registration | Oct 9, 2024 | — |
| POS AM | Filing | Oct 9, 2024 | — |
| 424B5 | Prospectus supplement | Aug 29, 2024 | — |
| 424B5 | Prospectus supplement | Aug 29, 2024 | — |
| POS AM | Filing | Apr 19, 2024 | — |
| S-1/A | Amended registration statement | Mar 26, 2024 | — |
| 424B3 | Prospectus | Feb 15, 2024 | — |
| 424B3 | Prospectus | Feb 14, 2024 | — |
| S-1 | Registration statement | Jan 17, 2024 | — |
| S-1/A | Amended registration statement | Nov 17, 2023 | — |
| S-1 | Registration statement | Nov 9, 2023 | — |
| S-8 | Employee stock plan registration | Oct 20, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| 424B3 | Prospectus | May 12, 2023 | — |
| POS AM | Filing | May 12, 2023 | — |
| S-1/A | Amended registration statement | May 9, 2023 | — |
| S-1/A | Amended registration statement | May 8, 2023 | — |
| S-1 | Registration statement | Apr 28, 2023 | — |
| S-3/A | Filing | Feb 16, 2023 | — |
| 424B5 | Prospectus supplement | Feb 6, 2023 | — |
| S-3 | Shelf registration | Jan 31, 2023 | — |
| S-3 | Shelf registration | Jan 9, 2023 | — |
| 424B4 | Prospectus | Jan 3, 2023 | — |
| S-3 | Shelf registration | Dec 19, 2022 | — |
| 424B4 | Prospectus | Dec 9, 2022 | — |
| S-1/A | Amended registration statement | Dec 5, 2022 | — |
| S-1/A | Amended registration statement | Dec 1, 2022 | — |
| S-1/A | Amended registration statement | Nov 18, 2022 | — |
| S-1/A | Amended registration statement | Nov 17, 2022 | — |
| S-1 | Registration statement | Oct 28, 2022 | — |
| 424B3 | Prospectus | Oct 28, 2022 | — |
| 424B3 | Prospectus | Sep 20, 2022 | — |
| 424B3 | Prospectus | Sep 9, 2022 | — |
| 424B3 | Prospectus | Aug 30, 2022 | — |
| S-3 | Shelf registration | Aug 19, 2022 | — |
| 424B3 | Prospectus | Aug 19, 2022 | — |
| 424B3 | Prospectus | Aug 19, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 424B3 | Prospectus | Aug 10, 2022 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| 424B3 | Prospectus | Aug 2, 2022 | — |
| S-3 | Shelf registration | Jul 27, 2022 | — |
| 424B3 | Prospectus | Jun 21, 2022 | — |
| 424B3 | Prospectus | Jun 21, 2022 | — |
| 424B8 | Filing | Jun 1, 2022 | — |
| 424B8 | Filing | Jun 1, 2022 | — |
| 424B8 | Filing | Jun 1, 2022 | — |
| 424B8 | Filing | Jun 1, 2022 | — |
| S-8 | Employee stock plan registration | Jan 31, 2022 | — |
| 424B3 | Prospectus | Jan 18, 2022 | — |
| 424B3 | Prospectus | Jan 18, 2022 | — |
| 424B3 | Prospectus | Dec 27, 2021 | — |
| 424B3 | Prospectus | Dec 27, 2021 | — |
| 424B3 | Prospectus | Nov 16, 2021 | — |
| 424B3 | Prospectus | Nov 16, 2021 | — |
| 424B3 | Prospectus | Nov 16, 2021 | — |
| 424B3 | Prospectus | Nov 16, 2021 | — |
| 424B3 | Prospectus | Nov 4, 2021 | — |
| S-1/A | Amended registration statement | Oct 29, 2021 | — |
| S-1 | Registration statement | Oct 25, 2021 | — |
| S-8 | Employee stock plan registration | Oct 7, 2021 | — |
| 424B3 | Prospectus | Sep 27, 2021 | — |
| S-1/A | Amended registration statement | Sep 22, 2021 | — |
| S-1 | Registration statement | Aug 9, 2021 | — |
| 424B3 | Prospectus | Jun 16, 2021 | — |
| S-4/A | Filing | Jun 14, 2021 | — |
| S-4/A | Filing | Jun 9, 2021 | — |
| S-4/A | Filing | May 3, 2021 | — |
| S-4/A | Filing | Apr 21, 2021 | — |
| S-4/A | Filing | Apr 19, 2021 | — |
| S-4/A | Filing | Apr 16, 2021 | — |
| S-4 | Registration for a merger or exchange | Mar 15, 2021 | — |
| 424B4 | Prospectus | Dec 1, 2017 | — |
| S-1/A | Amended registration statement | Dec 1, 2017 | — |
| S-1/A | Amended registration statement | Nov 28, 2017 | — |
| S-1/A | Amended registration statement | Nov 24, 2017 | — |
| S-1/A | Amended registration statement | Nov 17, 2017 | — |
| S-1 | Registration statement | Nov 3, 2017 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1716947
- Former names
- Leisure Acquisition Corp. (until Jun 30, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.